These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30714402)

  • 21. Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway.
    Zhou Y; Wu Y; Qin Y; Liu L; Wan J; Zou L; Zhang Q; Zhu J; Mi M
    PLoS One; 2016; 11(7):e0159191. PubMed ID: 27391974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.
    Dierick F; Héry T; Hoareau-Coudert B; Mougenot N; Monceau V; Claude C; Crisan M; Besson V; Dorfmüller P; Marodon G; Fadel E; Humbert M; Yaniz-Galende E; Hulot JS; Marazzi G; Sassoon D; Soubrier F; Nadaud S
    Circ Res; 2016 Mar; 118(5):822-33. PubMed ID: 26838788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARgamma and the pathobiology of pulmonary arterial hypertension.
    Rabinovitch M
    Adv Exp Med Biol; 2010; 661():447-58. PubMed ID: 20204748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.
    Wang AP; Li XH; Yang YM; Li WQ; Zhang W; Hu CP; Zhang Z; Li YJ
    PLoS One; 2015; 10(6):e0130806. PubMed ID: 26120832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
    Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
    Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.
    Blum JI; Bijli KM; Murphy TC; Kleinhenz JM; Hart CM
    Am J Med Sci; 2016 Jul; 352(1):71-9. PubMed ID: 27432037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Satoh T; Satoh K; Yaoita N; Kikuchi N; Omura J; Kurosawa R; Numano K; Al-Mamun E; Siddique MA; Sunamura S; Nogi M; Suzuki K; Miyata S; Morser J; Shimokawa H
    Circ Res; 2017 Apr; 120(8):1246-1262. PubMed ID: 28289017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19.
    Li X; Zhang Y; Su L; Cai L; Zhang C; Zhang J; Sun J; Chai M; Cai M; Wu Q; Zhang C; Yan X; Wang L; Huang X
    J Cell Mol Med; 2022 May; 26(10):3005-3021. PubMed ID: 35437883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation.
    Luo Y; Dong HY; Zhang B; Feng Z; Liu Y; Gao YQ; Dong MQ; Li ZC
    Hypertension; 2015 Feb; 65(2):414-20. PubMed ID: 25421979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch activation of Ca
    Guo Q; Xu H; Yang X; Zhao D; Liu S; Sun X; Huang JA
    Hypertens Res; 2017 Feb; 40(2):117-129. PubMed ID: 27581537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Ambalavanan N; Oparil S
    Life Sci; 2006 Aug; 79(14):1357-65. PubMed ID: 16714036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neohesperidin Exerts Lipid-Regulating Effects in vitro and in vivo via Fibroblast Growth Factor 21 and AMP-Activated Protein Kinase/Sirtuin Type 1/Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1α Signaling Axis.
    Wu H; Liu Y; Chen X; Zhu D; Ma J; Yan Y; Si M; Li X; Sun C; Yang B; He Q; Chen K
    Pharmacology; 2017; 100(3-4):115-126. PubMed ID: 28554169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
    Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
    EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.